Search For "zycov d"
More scientific data required on mixing of COVID-19 vaccine doses: Secreta
Updated : 4 years, 8 months ago IST
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
Read More
Discussion on pricing of Zydus Cadila's COVID-19 vaccine going on, decisio
Updated : 4 years, 8 months ago IST
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
Read More
Zydus Cadila to seek approval for two-dose regimen of its approved three-d
Updated : 4 years, 8 months ago IST
New Delhi [India], September 12 (ANI): Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India's drugs regulator f
Read More
Zydus Cadila's ZyCoV-D likely to be launched in early October: Sources
Updated : 4 years, 8 months ago IST
New Delhi [India], September 11 (ANI): Zydus Cadila's needle-free coronavirus vaccine-- ZyCoV-D-- is likely to be available by early October, sources told ANI on Saturday.
Read More
Adolescents likely to get ZyCoV-D COVID vaccine after four weeks
Updated : 4 years, 9 months ago IST
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 9 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
More clarity on ZyCOV-D vaccine price by next week, says Zydus Group MD Sh
Updated : 4 years, 9 months ago IST
New Delhi [India], August 21 (ANI): There will be more clarity on the price of its COVID-19 vaccine ZyCOV-D by next week, said Managing Director of Zydus Group Dr Sharvil Patel on Saturday.
Read More
Approval for world's first DNA-based 'ZyCov-D' vaccine is testimony to inn
Updated : 4 years, 9 months ago IST
New Delhi [India], August 20 (ANI): Prime Minister Narendra Modi on Friday said that the approval for the world's first DNA-based 'ZyCov-D' vaccine of Zydus Cadila group is a testimony to the innovative zeal of India's scientists.
Read More
India approves Zydus Cadila's ZyCoV-D vaccine for emergency use for adults
Updated : 4 years, 9 months ago IST
New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
Read More
Zydus Cadila likely to get emergency use approval for its COVID vaccine th
Updated : 4 years, 9 months ago IST
New Delhi [India], August 9 (ANI): Ahmedabad-based Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D is expected to get an emergency-use nod from the expert committee this week, sources said.
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 10 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DC
Updated : 4 years, 10 months ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More